Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Iftimie

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical Biochemistry|April 24, 2017
Paraoxonases and infectious diseasesJordi Camps, Simona Iftimie, Anabel García-Heredia, et al.
Biomolecules|July 29, 2025
Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial VirusJordi Camps, Simona Iftimie, Andrea Jiménez-Franco, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|March 30, 2023
The concentrations of essential/toxic elements in serum of COVID-19 patients are not directly related to the severity of the diseaseMontse Marquès, Simona Iftimie, Jordi Camps, et al.
Clinical Nuclear Medicine|February 26, 2014
Focal splenic FDG uptake in a patient with Kala-Azar (visceral leishmaniasis)Jordi Fuertes, Josep-Roland Garcia-Bennett, Simona Iftimie, et al.
Medical Hypotheses|February 28, 2022
Can COVID-19 vaccines relieve severe tension-type headache and migraine?Jordi González-Menacho, Mónica Villas-Roca, Helena Castañé, et al.
Chemico-Biological Interactions|May 18, 2023
Paraoxonase-1: How a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancerJordi Camps, Simona Iftimie, Meritxell Arenas, et al.
Antioxidants (Basel, Switzerland)|February 27, 2026
A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder CancerDavid Parada, Alina-Iuliana Onoiu, Simona Iftimie, et al.
Biomolecules|August 6, 2021
On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 UpdateJordi Camps, Helena Castañé, Elisabet Rodríguez-Tomàs, et al.
Atherosclerosis Plus|March 13, 2023
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 diseaseSandra Parra, Mireia Saballs, Mark DiNubile, et al.
Chemico-Biological Interactions|June 14, 2025
Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumoniaFrederic Ballester, Xavier Gabaldó-Barrios, Andrea Jiménez-Franco, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Biochemistry|April 24, 2017
Paraoxonases and infectious diseasesJordi Camps, Simona Iftimie, Anabel García-Heredia, et al.
Biomolecules|July 29, 2025
Metabolic Reprogramming in Respiratory Viral Infections: A Focus on SARS-CoV-2, Influenza, and Respiratory Syncytial VirusJordi Camps, Simona Iftimie, Andrea Jiménez-Franco, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|March 30, 2023
The concentrations of essential/toxic elements in serum of COVID-19 patients are not directly related to the severity of the diseaseMontse Marquès, Simona Iftimie, Jordi Camps, et al.
Clinical Nuclear Medicine|February 26, 2014
Focal splenic FDG uptake in a patient with Kala-Azar (visceral leishmaniasis)Jordi Fuertes, Josep-Roland Garcia-Bennett, Simona Iftimie, et al.
Medical Hypotheses|February 28, 2022
Can COVID-19 vaccines relieve severe tension-type headache and migraine?Jordi González-Menacho, Mónica Villas-Roca, Helena Castañé, et al.
Chemico-Biological Interactions|May 18, 2023
Paraoxonase-1: How a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancerJordi Camps, Simona Iftimie, Meritxell Arenas, et al.
Antioxidants (Basel, Switzerland)|February 27, 2026
A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder CancerDavid Parada, Alina-Iuliana Onoiu, Simona Iftimie, et al.
Biomolecules|August 6, 2021
On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 UpdateJordi Camps, Helena Castañé, Elisabet Rodríguez-Tomàs, et al.
Atherosclerosis Plus|March 13, 2023
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 diseaseSandra Parra, Mireia Saballs, Mark DiNubile, et al.
Chemico-Biological Interactions|June 14, 2025
Insights into the diagnostic and prognostic value of paraoxonase 1-related variables and inflammatory markers in community-acquired pneumoniaFrederic Ballester, Xavier Gabaldó-Barrios, Andrea Jiménez-Franco, et al.
Pageof 4